Diabetic chronic HCV patients and their response to interferon therapy

Changes in chemokines levels in relation to combined interferon and ribavirin therapy in Egyptian patients with chronic hepatitis C

Aetiology of anemia in chronic HCV patients receiving pegylated interferon plus ribavirin

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment

Fluvastatin as an adjuvant therapy with pegylated Interferon and Ribavirin in the treatment of chronic hepatitis C virus

Serum levels of AFP after interferon-based therapy with ribavirin for genotype 4 chronic HCV patients

The effect of dual therapy of pegylated interferon and ribavirin on viral load and liver enzymes of hepatitis c patients

Evaluation of post interferon therapy changes in chronic HCV patients : Clinical, Doppler ultrasonography and histopathological study

Changes in immunomodulators in relation to interferon therapy in hepatitis c virus infection